Dr. Martin offers a science-based explanation of how allografts—particularly Wharton's Jelly—contribute to structural support and localized tissue optimization through collagenic signaling. He encourages providers to move beyond the outdated “stem cell” terminology and focus on the well-characterized growth factor profiles found in structural tissue allografts. Dr. Martin also underscores the importance of using these materials within defined, localized applications and cautions against making non-compliant claims related to systemic effects or disease reversal.